Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Research & Development: 2020-2024

Historic Research & Development for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to $76.4 million.

  • Arcutis Biotherapeutics' Research & Development rose 0.53% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.1 million, marking a year-over-year decrease of 17.07%. This contributed to the annual value of $76.4 million for FY2024, which is 30.89% down from last year.
  • According to the latest figures from FY2024, Arcutis Biotherapeutics' Research & Development is $76.4 million, which was down 30.89% from $110.6 million recorded in FY2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Research & Development peaked at $182.4 million during FY2022, and registered a low of $76.4 million during FY2024.
  • In the last 3 years, Arcutis Biotherapeutics' Research & Development had a median value of $110.6 million in 2023 and averaged $123.1 million.
  • Its Research & Development has fluctuated over the past 5 years, first increased by 26.23% in 2021, then slumped by 39.39% in 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Research & Development (Yearly) stood at $115.3 million in 2020, then grew by 26.23% to $145.6 million in 2021, then rose by 25.33% to $182.4 million in 2022, then crashed by 39.39% to $110.6 million in 2023, then slumped by 30.89% to $76.4 million in 2024.